# Lexiscan(TM) Rb-82 Myocardial Perfusion PET: A Comparison With Dipyridamole Stress

> **NCT00808314** · PHASE4 · UNKNOWN · sponsor: **Cardiovascular Imaging Technologies** · enrollment: 32 (estimated)

## Conditions studied

- Coronary Artery Disease

## Interventions

- **DRUG:** Rest/Dipyridamole Stress Rb-82 Myocardial Perfusion PET/CT
- **DRUG:** Rest/Lexiscan(TM) Stress Rb-82 Myocardial Perfusion PET

## Key facts

- **NCT ID:** NCT00808314
- **Lead sponsor:** Cardiovascular Imaging Technologies
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2008-12
- **Primary completion:** 2010-12
- **Final completion:** 2012-09
- **Target enrollment:** 32 (ESTIMATED)
- **Last updated:** 2012-08-02

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00808314

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00808314, "Lexiscan(TM) Rb-82 Myocardial Perfusion PET: A Comparison With Dipyridamole Stress". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT00808314. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*